--- type: "News" locale: "en" url: "https://longbridge.com/en/news/285416593.md" description: "908 Devices shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY26 sales guidance above estimates." datetime: "2026-05-06T17:12:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285416593.md) - [en](https://longbridge.com/en/news/285416593.md) - [zh-HK](https://longbridge.com/zh-HK/news/285416593.md) generator: "portal-rs" --- # 908 Devices shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY26 sales guidance above estimates. ### Related Stocks - [MASS.US](https://longbridge.com/en/quote/MASS.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) ## Related News & Research - [908 Devices director Christopher D. Brown disposes of 30,000 common shares for $317,400](https://longbridge.com/en/news/298072400.md) - [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md) - [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md) - [908 Devices CEO Kevin J. Knopp disposes of USD 283,477.32 in common shares](https://longbridge.com/en/news/296148424.md) - [MASS: Handheld detection focus, recurring revenue, and regulatory shifts drive strong growth and profitability](https://longbridge.com/en/news/297072205.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**